Keep yourself up to date
SEATTLE, WA October 12, 2018 — Cyrus Biotechnology, a Seattle-based firm offering access to Rosetta, the most advanced software available for protein modeling and accelerated drug discovery, announced today that it will present at the 10th Annual Immunogenicity & Bioassay Summit, to be held in Washington DC on October 22-25, 2018. Dr. Indigo King, a […]
Cyrus growing its team to speed biologics and small molecule drug development software to market SEATTLE, WA August 6, 2018 — Cyrus Biotechnology, a biotechnology software company offering first-in-class tools for advanced protein modeling and discovery in drug development, announced today the appointment of Jake Litwicki as VP of Engineering. Jake will lead software engineering […]
Cyrus Biotechnology offers molecular scientists a cloud-based platform that allows them to design and build protein molecules. The software is based on a protein-modelling platform called Rosetta, which was first conceived and created at the University of Washington, and essentially allows the creation of entirely new types of proteins inside a computer. Cyrus Biotechnology brings this capability to the […]
SEATTLE — Cyrus Biotechnology, Inc., a Seattle-based firm offering access to Rosetta, the most advanced software available for protein modeling and accelerated drug discovery, announced today the general release of a new immune screening and prediction tool in their Cyrus Bench® platform. Cyrus customers can now drastically reduce immunogenicity in pre-clinical candidates, thereby decreasing the chance […]
SEATTLE, April 18, 2018 — Cyrus Biotechnology, Inc., a biotechnology software company offering the most advanced protein modeling and design capabilities to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is pleased to announce its participation in the 14th Annual PEGS Boston Protein Engineering Summit in Boston, from April 30th through May 3rd. Dr. […]